Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
India accounts for 60% of the world's vaccines and
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
Alembic Pharmaceutica
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Mi
Under the conditions of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and roughly 40 employees will become part of Thermo Fisher’s Biosciences company. Propel Labs will continue to function as a separate entity and serve its existing customers.
“Cell sorting is an essential discovery tool used by many of our customers, allowing for the separation of specific cell types from complex samples. A first-of-its kind, the Bigfoot Spectral Cell Sorter brings more powerful sorting capabilities, faster throughput and novel safety features complementing our already strong flow cytometry offering,” says Mark Stevenson, executive vice president and chief operating officer of Thermo Fisher Scientific. “As the market for cell and gene therapies, immuno-oncology and other promising medicines drive increased expectations from researchers, we are really well positioned to support our customers in their work to improve healthcare outcomes.”
Featured image: Bigfoot Spectral Cell Sorter (Courtesy: Thermo Fisher Scientific)
